US equities
|
SPCX
$167.28
▲+5.23%
NVDA
$236.25
▲+0.98%
MU
$1,066.73
▼-0.76%
TSLA
$378.40
▲+2.11%
MSFT
$526.31
▲+1.70%
SNDK
$1,709.82
▼-0.59%
INTC
$117.15
▼-1.83%
META
$744.24
▲+2.22%
SPCX
$167.28
▲+5.23%
NVDA
$236.25
▲+0.98%
MU
$1,066.73
▼-0.76%
TSLA
$378.40
▲+2.11%
MSFT
$526.31
▲+1.70%
SNDK
$1,709.82
▼-0.59%
INTC
$117.15
▼-1.83%
META
$744.24
▲+2.22%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
GeoVax Labs, Inc. - Common Stock
(NQ:
GOVX
)
0.3684
+0.0484 (+15.12%)
Delayed Quote
Updated: 12:46 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about GeoVax Labs, Inc. - Common Stock
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
25
26
Next >
GeoVax to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025
March 17, 2025
GeoVax to Host Conference Call at 4:30 PM ET
Via
TheNewswire.com
GeoVax Labs Inc. (NASDAQ: GOVX) Featured in Coverage of the 37th Annual ROTH Conference
March 12, 2025
Via
Investor Brand Network
GeoVax Establishing Strategic Presence in Europe With Initial Footprint in the UK
March 12, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax Establishing Strategic Presence in Europe With Initial Footprint in the UK
March 12, 2025
Hub to Advance Global Vaccine and Immuno-Oncology Development
Via
TheNewswire.com
GeoVax Pledges Continued Support for Vaccine Innovation, Transparency, and Public Health
February 18, 2025
GeoVax’s Vaccine Development Programs Align with Anticipated HHS Focus on Vaccine Safety, Diversification and Domestic Biosecurity
Via
TheNewswire.com
Strengthening America's Biosecurity: GeoVax Advances Domestic Vaccine Capability
January 29, 2025
Addressing Critical U.S. Vulnerabilities in Vaccine Supply and National Preparedness
Via
TheNewswire.com
Topics
Supply Chain
GeoVax to Present at the 37th Annual Roth Conference
March 11, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax to Present at the 37th Annual Roth Conference
March 11, 2025
ATLANTA, GA - March 11, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced today...
Via
TheNewswire.com
Registration is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event MPOX 2025: Navigating the Global Public Health Emergency Featuring GeoVax CEO On March 6, 2025
March 04, 2025
ATLANTA, GA - March 4, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases,...
Via
TheNewswire.com
Registration is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event MPOX 2025: Navigating the Global Public Health Emergency Featuring GeoVax CEO On March 6, 2025
March 04, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax Highlights the Critical Role of MVA-Based Vaccines in U.S. Biodefense Strategy
March 03, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Economy
GeoVax Highlights the Critical Role of MVA-Based Vaccines in U.S. Biodefense Strategy
March 03, 2025
GeoVax’s GEO-MVA: Strengthening U.S. Biodefense
Via
TheNewswire.com
Topics
Economy
GeoVax Response to WHO's Third Declaration of Mpox as a Public Health Emergency of International Concern
February 27, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Death
GeoVax Response to WHO's Third Declaration of Mpox as a Public Health Emergency of International Concern
February 27, 2025
GeoVax Advancing GEO-MVA Vaccine Candidate to Bolster Global Supply Options
Via
TheNewswire.com
Topics
Death
GeoVax Highlights the Role of MVA-Based Vaccines in Advancing Public Health Preparedness
February 24, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax Highlights the Role of MVA-Based Vaccines in Advancing Public Health Preparedness
February 24, 2025
Recent Studies Support Diversified Vaccine Strategies, Aligning with GeoVax’s MVA-Based GEO-CM04S1 for Enhanced Protection, Particularly for Immunocompromised Populations
Via
TheNewswire.com
Mpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply Diversification
February 19, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Economy
Supply Chain
Mpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply Diversification
February 19, 2025
GeoVax Advances GEO-MVA to Strengthen U.S. and Global Readiness
Via
TheNewswire.com
Topics
Economy
Supply Chain
GeoVax Pledges Continued Support for Vaccine Innovation, Transparency, and Public Health
February 18, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax to Present at the Emerging Growth Conference on February 19, 2025
February 17, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax to Present at the Emerging Growth Conference on February 19, 2025
February 17, 2025
Company to Provide an Update on Its Mpox Vaccine Program
Via
TheNewswire.com
GeoVax Congratulates Dr. Valerie Montgomery Rice on Receiving the 2025 Healthcare Champions Lifetime Achievement Award
February 11, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax Congratulates Dr. Valerie Montgomery Rice on Receiving the 2025 Healthcare Champions Lifetime Achievement Award
February 11, 2025
Recognizing a Visionary Leader in Advancing Healthcare Access for Minority and Vulnerable Populations Worldwide
Via
TheNewswire.com
GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs
February 05, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Artificial Intelligence
GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs
February 05, 2025
Strategic Progress Across COVID-19, Mpox, Oncology Therapies and AI Integration Positions GeoVax for Strong Momentum
Via
TheNewswire.com
Topics
Artificial Intelligence
GeoVax to Showcase Advancements in Vaccines & Immunotherapies at the 2025 BIO CEO & Investor Conference
February 04, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax to Showcase Advancements in Vaccines & Immunotherapies at the 2025 BIO CEO & Investor Conference
February 04, 2025
ATLANTA, GA - February 4, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced...
Via
TheNewswire.com
GeoVax Announces Strategic Integration of AI in Support of President Trump's Stargate Initiative
February 03, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Artificial Intelligence
Government
GeoVax Announces Strategic Integration of AI in Support of President Trump's Stargate Initiative
February 03, 2025
Harnessing AI to Revolutionize Vaccine and Therapy Development
Via
TheNewswire.com
Topics
Artificial Intelligence
Government
Strengthening America's Biosecurity: GeoVax Advances Domestic Vaccine Capability
January 29, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Supply Chain
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
25
26
Next >
